Opendata, web and dolomites

rev.ng SIGNED

rev.ng: a tool for security assessments of emerging and legacy platforms

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "rev.ng" data sheet

The following table provides information about the project.

Coordinator
REV.NG SOCIETA' A RESPONSABILITA' LIMITATA SEMPLIFICATA 

Organization address
address: VIA SAN MARTINO 23
city: REGGIO EMILIA RE
postcode: 42121
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website https://rev.ng
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-10-01   to  2019-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    REV.NG SOCIETA' A RESPONSABILITA' LIMITATA SEMPLIFICATA IT (REGGIO EMILIA RE) coordinator 50˙000.00

Map

 Project objective

Cyberattacks are one of the most challenging threats modern societies have to face. In fact, along with the growth of IT infrastructure, threats against them have been raising too.

While a lot is being done, certain environments, in particular in the IoT area, are receiving little attention by cybersecurity experts.

One of the key reasons for this is the almost total lack of tools to perform security assessments on them. Specifically, these areas lack reverse engineering tools, which allow analysts to analyze software for which the source code is not available.

The absence of reverse engineering tools makes it extremely hard, if not impossible, to perform security assessments on such platforms. The reason for this is the dominance of the market leader (turnover 14000000 EUR in 2017, EBITDA of 13000000), which has little incentive to innovate in market niches which would justify the investment.

In this proposal, we aim to bring to commercial maturity rev.ng, a tool developed by our company. rev.ng is the result of a multi-year research effort, with the aim of being able to handle a diverse set of platforms in a unified way. This approach is radically revolutionary in the reverse engineering field and allows us to target market niches which would not be profitable to our competitors.

Our product has already been validated both by SMEs performing security assessments and large corporations performing large scale analysis of software such as Google.

The goal of this proposal is getting the resources to refine some critical aspects of the feasibility study we already performed, that will lead us to devise the best path to transform our small company, currently mainly focused on consulting, into a scalable company developing a state-of-the-art reverse engineering product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REV.NG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REV.NG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

BEMYEYES (2019)

Specialized Help from Be My Eyes – harnessing technology to connect companies directly with their blind and visually impaired users

Read More  

NextGen-O2k (2019)

Next Generation Instrument for In-Depth Analysis of Mitochondrial Fitness

Read More  

PD-Watch (2019)

Wearable technology for the selective detection and continuous monitoring of movement disorders related to Parkinson’s disease

Read More